← Open Payments lookup

ABBEY ROBINSON: Open Payments

NPI 1053000182 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,357 in 119 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $550 · 2025 $2,357

Food & beverage: $2,357
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$346
ABBVIE INC.28$293
Novo Nordisk Inc15$245
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$231
Axsome Therapeutics, Inc.8$199
Otsuka America Pharmaceutical, Inc.4$174
Lilly USA, LLC9$149
Kowa Pharmaceuticals America, Inc.1$114
Amgen Inc.6$99
Phathom Pharmaceuticals, Inc.6$91

Products named: AIRSUPRA, CAPLYTA, REXULTI, Wegovy, VRAYLAR, Symbravo, ZORYVE, VOQUEZNA.

Industry payments across AL — which companies pay providers there.